These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29958681)

  • 1. Semi-preparative high-resolution recycling liquid chromatography.
    Gritti F; Basile M; Cormier S; Fogwill M; Gilar M; McDonald T; Riley F; Yan Q
    J Chromatogr A; 2018 Sep; 1566():64-78. PubMed ID: 29958681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebirth of recycling liquid chromatography with modern chromatographic columns : Extension to gradient elution.
    Gritti F
    J Chromatogr A; 2021 Sep; 1653():462424. PubMed ID: 34340057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-preparative LC-SPE-cryoflow NMR for impurity identifications: use of mother liquor as a better source of impurities.
    Rinaldi F; Fan J; Pathirana C; Palaniswamy V
    Magn Reson Chem; 2013 Sep; 51(9):517-22. PubMed ID: 23788325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ideal versus real automated twin column recycling chromatography process.
    Gritti F; Leal M; McDonald T; Gilar M
    J Chromatogr A; 2017 Jul; 1508():81-94. PubMed ID: 28610798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance optimization of ultra high-resolution recycling liquid chromatography.
    Gritti F; Cormier S
    J Chromatogr A; 2018 Jan; 1532():74-88. PubMed ID: 29180221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Separation and identification of impurities from intermediates of istradefylline].
    Wang Y; Lü X; Xu H; Meng Z; Li J; Xu Z; Xue M
    Se Pu; 2021 Apr; 39(4):430-436. PubMed ID: 34227764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification, isolation, characterization and response factor determination of process-related impurity in meprobamate drug substance.
    Karthikeyan K; Arularasu GT; Murali V; Pillai KC
    J Pharm Biomed Anal; 2011 Jan; 54(1):208-12. PubMed ID: 20727702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization and troubleshooting of preparative liquid chromatography using statistical design of experiments: Four small-molecule case studies.
    Hochdorfer TS; Wang K
    J Chromatogr A; 2022 Aug; 1676():463212. PubMed ID: 35716463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and Structural Elucidation of an Unknown Impurity in Prasugrel by Semi-Preparative Liquid Chromatography.
    Liu C; Yu Z; Wang F; Zhong X; Jiang L; Zhang F; Tang Y; Yan Z; Zeng S; Pu T
    J Chromatogr Sci; 2015 Aug; 53(7):1163-8. PubMed ID: 25644811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of the impurity in auramine O by high performance liquid chromatography-ion trap-time of flight mass spectrometry and preparation of the auramine O reference standard by preparative high performance liquid chromatography].
    Che F; Lu Y; Xi X; Lan T; Wei Y
    Se Pu; 2019 Mar; 37(3):299-304. PubMed ID: 30900859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An artifactual solution degradant of pregabalin due to adduct formation with acetonitrile catalyzed by alkaline impurities during HPLC sample preparation.
    Lin J; Liu X; Wang J; Li D; Zhu W; Chen W; Zhang X; Li Q; Li M
    J Pharm Biomed Anal; 2019 Oct; 175():112788. PubMed ID: 31382116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution degradant of mirabegron extended release tablets resulting from a Strecker-like reaction between mirabegron, minute amounts of hydrogen cyanide in acetonitrile, and formaldehyde in PEG during sample preparation.
    Lin J; Huang T; Feng M; Li D; Zhao D; Wang J; Jin J; Zhu W; Li M
    J Pharm Biomed Anal; 2019 May; 168():181-188. PubMed ID: 30818256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico robustness testing of a compendial HPLC purity method by using of a multidimensional design space build by chromatography modeling-Case study pramipexole.
    Schmidt AH; Stanic M; Molnár I
    J Pharm Biomed Anal; 2014 Mar; 91():97-107. PubMed ID: 24440825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural elucidation of a dimeric impurity in the process development of ceftolozane using LC/HRMS and 2D-NMR.
    Liao J; Sheng H; Saurí J; Xiang R; Martin G
    J Pharm Biomed Anal; 2019 Sep; 174():242-247. PubMed ID: 31181486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation and structural characterization of unknown impurity in vancomycin by two-dimensional preparative liquid chromatography, LC-MS and NMR.
    Wang X; Qiu Y; Wen H; Weng R; Chen D; Liu H
    J Pharm Biomed Anal; 2023 Aug; 232():115403. PubMed ID: 37120972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities--part II.
    Háda V; Dubrovay Z; Lakó-Futó A; Galambos J; Gulyás Z; Aranyi A; Szántay C
    J Pharm Biomed Anal; 2013 Oct; 84():309-22. PubMed ID: 23177164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, characterization and quantification of a new impurity in deferasirox active pharmaceutical ingredient by LC-ESI-QT/MS/MS.
    Thomas S; Chandra Joshi S; Vir D; Agarwal A; Rao RD; Sridhar I; Xavier CM; Mathela CS
    J Pharm Biomed Anal; 2012 Apr; 63():112-9. PubMed ID: 22361658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
    Thomas S; Mathela CS; Agarwal A; Paul SK
    J Pharm Biomed Anal; 2011 Sep; 56(2):423-8. PubMed ID: 21676571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.